Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
-
Shares outstanding
-
316M
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
1.21M
-
Shares change
-
0
-
Total reported value, excl. options
-
$2.97M
-
Price
-
$2.23
Significant Holders of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) as of Q2 2025
2 filings reported holding EVAX - Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share as of Q2 2025.
Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.21M shares
of 316M outstanding shares and own 0.38% of the company stock.
Largest 2 shareholders include Merck & Co., Inc. (1.21M shares) and RHUMBLINE ADVISERS (2 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.